首页> 美国卫生研究院文献>Journal of Clinical Medicine >Quantified Vascular Calcification at the Dialysis Access Site: Correlations with the Coronary Artery Calcium Score and Survival Analysis of Access and Cardiovascular Outcomes
【2h】

Quantified Vascular Calcification at the Dialysis Access Site: Correlations with the Coronary Artery Calcium Score and Survival Analysis of Access and Cardiovascular Outcomes

机译:透析通路部位的量化血管钙化:与冠状动脉钙分数的关系以及通路和心血管结局的生存分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vascular calcification is a major contributor to mortality in end-stage renal disease (ESRD) patients. In this study, we investigated whether there was a correlation between the coronary artery calcium score (CACS) and the vascular calcification score (VCS), and whether higher VCS increased the incidence of interventions and major adverse cardiac and cerebrovascular events (MACCE). ECG-gated CT, including vascular access and the coronary vessel, was taken. CACS and VCS were calculated by the Agatston method. A comparison of CACS and survival analysis according to VCS groups was performed. Using a cutoff of VCS = 500, 77 patients were divided into two groups. The vintage was significantly older in the higher VCS group. The median CACS was higher in the higher VCS group (21 [0, 171] vs. 552 [93, 2430], < 0.001). The hazard ratio (HR) for interventions and MACCEs in the higher VCS group increased by 3.2 and 2.3, respectively. Additionally, a longer duration of hemodialysis and higher magnesium levels (>2.5 mg/dL) showed lower HRs for interventions (<1). We quantified VCS and found that it was associated with the CACS. Additionally, higher VCS increased the risk of access interventions and MACCE. VCS of the access site may be suggested as a biomarker to predict ESRD patients.
机译:血管钙化是终末期肾病(ESRD)患者死亡率的主要因素。在这项研究中,我们调查了冠状动脉钙化评分(CACS)和血管钙化评分(VCS)之间是否存在相关性,以及较高的VCS是否增加了干预措施和严重的心脑血管事件(MACCE)的发生率。进行ECG门控CT,包括血管通路和冠状动脉。 CACS和VCS通过Agatston方法计算。根据VCS组比较了CACS和生存分析。使用VCS = 500的临界值,将77例患者分为两组。在较高的VCS组中,该年份明显偏旧。较高的VCS组中位CACS较高(21 [0,171]与552 [93,2430],<0.001)。较高的VCS组中干预措施和MACCE的危险比(HR)分别增加了3.2和2.3。此外,血液透析的持续时间较长,镁水平较高(> 2.5 mg / dL),干预的HR较低(<1)。我们量化了VCS,发现它与CACS相关。此外,较高的VCS会增加访问干预和MACCE的风险。可以建议将进入部位的VCS用作预测ESRD患者的生物标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号